BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22147656)

  • 21. Localization and regulation of SR-BI in membrane rafts of HepG2 cells.
    Rhainds D; Bourgeois P; Bourret G; Huard K; Falstrault L; Brissette L
    J Cell Sci; 2004 Jul; 117(Pt 15):3095-105. PubMed ID: 15226391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation of high-density lipoprotein and the functionality of aldosterone release in type 2 diabetes.
    Kuwano T; Miura SI; Norimatsu K; Arimura T; Shiga Y; Tomita S; Nakayama A; Matsuo Y; Imaizumi S; Saku K
    Hypertens Res; 2017 Mar; 40(3):271-276. PubMed ID: 27733768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial cell-mediated regulation of aldosterone release from human adrenocortical cells.
    Ansurudeen I; Kopprasch S; Ehrhart-Bornstein M; Bornstein SR; Willenberg HS
    Mol Cell Endocrinol; 2007 Feb; 265-266():150-6. PubMed ID: 17257743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azelnidipine inhibits aldosterone synthesis and secretion in human adrenocortical cell line NCI-H295R.
    Isaka T; Ikeda K; Takada Y; Inada Y; Tojo K; Tajima N
    Eur J Pharmacol; 2009 Mar; 605(1-3):49-52. PubMed ID: 19168055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D4 dopamine receptor enhances angiotensin II-stimulated aldosterone secretion through PKC-epsilon and calcium signaling.
    Chang HW; Wu VC; Huang CY; Huang HY; Chen YM; Chu TS; Wu KD; Hsieh BS
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E622-9. PubMed ID: 18171914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
    Rhainds D; Brodeur M; Lapointe J; Charpentier D; Falstrault L; Brissette L
    Biochemistry; 2003 Jun; 42(24):7527-38. PubMed ID: 12809509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of adrenal aldosterone release by oxidative modification of low-density lipoprotein.
    Ansurudeen I; Pietzsch J; Graessler J; Ehrhart-Bornstein M; Saha S; Bornstein SR; Kopprasch S
    Am J Hypertens; 2010 Oct; 23(10):1061-8. PubMed ID: 20559286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polychlorinated biphenyl 126 stimulates basal and inducible aldosterone biosynthesis of human adrenocortical H295R cells.
    Li LA; Wang PW; Chang LW
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):92-102. PubMed ID: 14962509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dkk3 is a component of the genetic circuitry regulating aldosterone biosynthesis in the adrenal cortex.
    El Wakil A; Bandulik S; Guy N; Bendahhou S; Zennaro MC; Niehrs C; Mari B; Warth R; Barhanin J; Lalli E
    Hum Mol Genet; 2012 Nov; 21(22):4922-9. PubMed ID: 22918120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aging and Adrenal Aldosterone Production.
    Nanba K; Vaidya A; Rainey WE
    Hypertension; 2018 Feb; 71(2):218-223. PubMed ID: 29229745
    [No Abstract]   [Full Text] [Related]  

  • 31. Adrenal histopathology in primary aldosteronism: is it time for a change?
    Gioco F; Seccia TM; Gomez-Sanchez EP; Rossi GP; Gomez-Sanchez CE
    Hypertension; 2015 Oct; 66(4):724-30. PubMed ID: 26238443
    [No Abstract]   [Full Text] [Related]  

  • 32. Links between aldosterone excess and metabolic complications: A comprehensive review.
    Bothou C; Beuschlein F; Spyroglou A
    Diabetes Metab; 2020 Feb; 46(1):1-7. PubMed ID: 30825519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathophysiological and clinical problems of aldosterone].
    KOKOT F
    Postepy Hig Med Dosw; 1962; 16():105-33. PubMed ID: 14457923
    [No Abstract]   [Full Text] [Related]  

  • 34. Modified lipoproteins in diabetes.
    Böttiger LE
    J Intern Med; 1995 Sep; 238(3):293. PubMed ID: 7673861
    [No Abstract]   [Full Text] [Related]  

  • 35. The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review.
    Manosroi W; Phudphong P; Atthakomol P; Phimphilai M
    BMC Endocr Disord; 2022 Aug; 22(1):217. PubMed ID: 36045354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production.
    Tsai YY; Rainey WE; Bollag WB
    J Endocrinol; 2017 Feb; 232(2):R115-R129. PubMed ID: 27913572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity, hypertension and aldosterone: is leptin the link?
    Xie D; Bollag WB
    J Endocrinol; 2016 Jul; 230(1):F7-F11. PubMed ID: 27252389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VLDL-activated cell signaling pathways that stimulate adrenal cell aldosterone production.
    Tsai YY; Rainey WE; Johnson MH; Bollag WB
    Mol Cell Endocrinol; 2016 Sep; 433():138-46. PubMed ID: 27222295
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.